
SPRAVATO® (esketamine): A Prescription Nasal Spray | SPRAVATO®
SPRAVATO® (esketamine) CIII nasal spray is a derivative of ketamine. SPRAVATO® is an FDA-approved nasal spray for treatment-resistant depression; it is also approved to treat depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions.
SPRAVATO® (esketamine): A Prescription Nasal Spray | SPRAVATO®
What is the most important information I should know about SPRAVATO ®? SPRAVATO ® can cause serious side effects, including: Sedation, dissociation, and respiratory depression.
SPRAVATO® (esketamine): A Prescription Nasal Spray | SPRAVATO®
Learn about SPRAVATO® (esketamine) CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.
SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: • Adults with treatment-resistant depression (TRD) • Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions
SPRAVATO® is a non-competitive N-methyl D-aspartate (NMDA) receptor antagonist indicated, in conjunction with an oral antidepressant, for the treatment of: • Treatment-resistant depression (TRD) in adults.
SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: • Adults with treatment-resistant depression (TRD) SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
• are allergic to esketamine, ketamine, or any of the other ingredients in SPRAVATO®. If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
SPRAVATO
SPRAVATO
SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: • Adults with treatment-resistant depression (TRD) • Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions
You must be enrolled in the SPRAVATO withMe Savings Program before your treatment date in order to receive a rebate for your SPRAVATO® medication. You can enroll online at SPRAVATOwithMePatientAuth.com or by calling 844-4S-WITHME (844-479-4846).